SavedAdd your journal

Journals / Retina-Vitreus / 2016 / Cilt: 24 - Sayı: 4

The Relationship Between Retinal Vein Occlusions and ABO (H) Blood Groups

Retinal Ven Tıkanıklıkları ve ABO (H) Kan Grupları Arasındaki İlişki*

Mustafa GÖK
Aslıhan UZUN
Hasan Burhanettin KAPTI
Özgür KARA
Pages
280–284
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Having a non-O blood group can be associated with an increased risk of RVO

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the relationship between ABO (H) blood groups and retinal vein occlusions.
📊
Key Findings & Data:Materials and Methods: Medical records of 54 patients diagnosed with retinal vein occlusion (RVO) and 47 age and sex matched individuals as control group were reviewed retrospectively.
💡
Conclusion & Impact:Conclusion: Having a non-O blood group can be associated with an increased risk of RVO
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the relationship between ABO (H) blood groups and retinal vein occlusions. Materials and Methods: Medical records of 54 patients diagnosed with retinal vein occlusion (RVO) and 47 age and sex matched individuals as control group were reviewed retrospectively. ABO(H) blood groups, Rh factors, the history of diabetes mellitus, hypertension, smoking, deep venous thrombosis, or cerebrovascular occlusion were recorded. All patients were divided into two subgroups; patients with central retinal vein occlusion (CRVO, n=22) and patients with branch retinal vein occlusion (BRVO, n=32). The frequencies of ABO (H) blood groups, Rh factors and other parameters in RVO group, CRVO and BRVO subgroups were analyzed statistically. Results: The frequency of non-O blood groups was statistically higher in RVO group than control group (p<=0.017, OR: 0.37 CI: 0.16-0.84). Although the frequency of A and B blood groups were statistically higher in RVO group, there was no significant difference in AB blood group between RVO and control group. The frequency of non-O blood groups was insignificantly higher in BRVO subgroup whereas non-O blood groups were significantly higher in CRVO subgroup (p<=0.015). The distribution of Rh groups was not statistically different in all groups. Moreover there was no statistically significant difference in ABO(H) (p<=0.160, OR: 2.71 CI: 0.65-11.24) and Rh groups between CRVO and BRVO subgroups. Conclusion: Having a non-O blood group can be associated with an increased risk of RVO

Özet

Amaç: Retinal ven tıkanıklıkları (RVT) ve ABO(H) kan grupları arasındaki ilişkinin değerlendirilmesi.Gereç ve Yöntem: Bu geriye dönük çalışmada RVT tanılı 54 (37 erkek/17 kadın, ortalama yaş: 66.19±10.27) ve kontrol grubu olarak 47 (30 erkek/17 kadın, ortalama yaş: 62.96±7.79) bireyin medikal kayıtları incelendi. Hasta ve kontrol grubunda, ABO(H) kan grubu ve Rh faktör dağılımı, diabet (DM) ve hipertansiyon (HT) varlığı, sigara kullanımı, geçirilmiş derin ven trombozu (DVT) ve serebrovasküler hastalık (SVH) öyküsü gibi bilgiler kaydedildi. RVT tanılı hastalar santral retinal ven tıkanıklığı (SRVT) olan 22 hasta, retinal ven dal tıkanıklığı olan (RVDT) 32 hasta olarak iki alt gruba ayrıldı. RVT ve alt grupları ile kontrol grubu arasında ABO(H) kan grubu, Rh grubu dağılımı ve diğer parametreler açısından istatistiksel karşılaştırma yapıldı. Bulgular: O dışı kan grubu sıklığı RVT grubunda kontrol grubuna göre istatistiksel olarak anlamlı derecede fazla idi (p<=0.017, OO: 0.37 GA: 0.16-0.84). A ve B kan grubu sıklığı RVT grubunda kontrol grubuna göre anlamlı derecede fazla iken AB kan grubu sıklığı açısından iki grup arasında anlamlı fark yoktu. RVDT grubunda O dışı kan grubu sıklığı kontrol grubuna göre anlamlı olmamakla beraber daha fazla iken SRVT grubunda anlamlı olarak daha fazla idi (p<=0.015). Rh faktörü dağılımı açısından tüm gruplar arasında istatistiksel olarak anlamlı fark yoktu. Yine ABO(H) kan grubu dağılımı açısından RVDT ve SRVT alt grupları arasında anlamlı fark yoktu (p<=0.160, OO: 2.71 GA: 0.65-11.24). Sonuç: O dışı kan grubuna sahip bireylerde retinal ven tıkanıklığı için artmış bir riskten söz edilebilir.

🔖

Cite This Article

GÖK, M., UZUN, A., KAPTI, H. B., KARA, Ö. (2016). The Relationship Between Retinal Vein Occlusions and ABO (H) Blood Groups. Retina-Vitreus, Cilt: 24 - Sayı: 4, 280–284. https://ajindex.com/articles/307988

References (14)

  1. The Branch Vein Occlusion Study Group. Argon laser photocoagula- tion for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271-82.
  2. Staurenghi G, Lonati C, Aschero M et al. Arteriovenous crossing as a risk factor in branch retinal vein occlusion. Am J Ophthalmol 1994;117:211-3.
  3. Zhou JQ, Xu L, Wang S et al. The 10-year incidence and risk fac- tors of retinal vein occlusion: the Beijing eye study. Ophthalmology 2013;120:803-8.
  4. Frangieh GT, Green WR, Barraquer-Somers E et al. Histopatholo- gic study of nine branch retinal vein occlusions. Arch Ophthalmol 1982;100:1132-40.
  5. Clark P, Wu O. ABO blood groups and thrombosis: a causal association, but is there value in screening? Future Cardiol 2011;7:191-201.
  6. Zhou S, Welsby I. Is ABO blood group truly a risk factor for thrombosis and adverse outcomes? World J Cardiol. 2014 26;6:985-92. White LE. Retinal venous occlusion and ABO blood-groups. N Z Med J. 1978 22;87:124-6.
  7. Parr JC, White LE. ABO blood-groups and the visual outcome of a retinal venous occlusion. Trans Ophthalmol Soc N Z. 1978;30:19-22.
  8. Zhao J, Sastry SM, Sperduto RD et al. Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group. Ophthalmology. 1993;100:423-8. Gutman FA. Evaluation of a patient with central retinal vein occlusion. Ophthalmology. 1983;90:481-3.
  9. Ciardella AP, Clarkson JG, Guyer DR et al. Central retinal vein occlısion: a primer and review. In: Yanuzzi LA, ed. Retina-Vitreous-Macular. New York: W.B Saunders 1999.
  10. Klein R, Klein BE, Moss SE et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133-41; discussion 141-3. Risk factors for central retinal vein occlusion. The Eye Disease CaseControl Study Group. Arch Ophthalmol. 1996;114:545-54.
  11. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol. 1996;114):1243-7.
  12. Stem MS, Talwar N, Comer GM et al. A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology. 2013;120:362-70.
  13. O'Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008;126:692-9.
  14. Rehak J, Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res. 2008;33:111-31. Janssen MC, den Heijer M, Cruysberg JR et al. Retinal vein occlusion: a form of venous thrombosis or a